Rvl Pharmaceuticals Plc Stock Fundamentals
RVL Pharmaceuticals' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting RVL Stock price.
RVL |
RVL Pharmaceuticals PLC Company Return On Equity Analysis
RVL Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current RVL Pharmaceuticals Return On Equity | -1.82 |
Most of RVL Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RVL Pharmaceuticals PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, RVL Pharmaceuticals PLC has a Return On Equity of -1.8244. This is 92.39% lower than that of the Biotechnology sector and 95.0% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
RVL Pharmaceuticals PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RVL Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare RVL Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RVL Pharmaceuticals competition to find correlations between indicators driving RVL Pharmaceuticals's intrinsic value. More Info.RVL Pharmaceuticals PLC is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value RVL Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.RVL Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RVL Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RVL Pharmaceuticals could also be used in its relative valuation, which is a method of valuing RVL Pharmaceuticals by comparing valuation metrics of similar companies.RVL Pharmaceuticals is currently under evaluation in return on equity category among its peers.
RVL Fundamentals
| Return On Equity | -1.82 | |||
| Return On Asset | -0.24 | |||
| Profit Margin | (1.85) % | |||
| Operating Margin | (0.98) % | |||
| Current Valuation | 41.79 M | |||
| Shares Outstanding | 111.41 M | |||
| Shares Owned By Insiders | 27.00 % | |||
| Shares Owned By Institutions | 49.09 % | |||
| Number Of Shares Shorted | 3.28 M | |||
| Price To Book | 1.94 X | |||
| Price To Sales | 2.92 X | |||
| Revenue | 49.72 M | |||
| Gross Profit | 43.06 M | |||
| EBITDA | (36.19 M) | |||
| Net Income | (51.69 M) | |||
| Cash And Equivalents | 27.41 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 57.49 M | |||
| Debt To Equity | 0.76 % | |||
| Current Ratio | 2.17 X | |||
| Book Value Per Share | 0.16 X | |||
| Cash Flow From Operations | (37.81 M) | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | (0.71) X | |||
| Target Price | 3.2 | |||
| Number Of Employees | 125 | |||
| Beta | 1.09 | |||
| Market Capitalization | 3.14 M | |||
| Total Asset | 128.51 M | |||
| Retained Earnings | (569.22 M) | |||
| Working Capital | 37.25 M | |||
| Z Score | -6.36 | |||
| Net Asset | 128.51 M |
Pair Trading with RVL Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RVL Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RVL Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Lennar could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lennar when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lennar - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lennar to buy it.
The correlation of Lennar is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lennar moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lennar moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lennar can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in RVL Stock
If you are still planning to invest in RVL Pharmaceuticals PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RVL Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |